SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CVS Health Corp – ‘10-K’ for 12/31/19 – ‘EX-10.27’

On:  Tuesday, 2/18/20, at 6:26am ET   ·   For:  12/31/19   ·   Accession #:  64803-20-7   ·   File #:  1-01011

Previous ‘10-K’:  ‘10-K’ on 2/28/19 for 12/31/18   ·   Next:  ‘10-K’ on 2/16/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/7/24 for 12/31/23   ·   12 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/18/20  CVS Health Corp                   10-K       12/31/19  147:29M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.94M 
 2: EX-4.15     Instrument Defining the Rights of Security Holders  HTML     53K 
 3: EX-10.11    Material Contract                                   HTML    185K 
 4: EX-10.14    Material Contract                                   HTML    230K 
 5: EX-10.27    Material Contract                                   HTML     66K 
 6: EX-10.48    Material Contract                                   HTML     96K 
 7: EX-10.54    Material Contract                                   HTML     96K 
 8: EX-10.56    Material Contract                                   HTML     97K 
 9: EX-21.1     Subsidiaries List                                   HTML    170K 
10: EX-23.1     Consent of Experts or Counsel                       HTML     39K 
11: EX-31.1     Certification -- §302 - SOA'02                      HTML     45K 
12: EX-31.2     Certification -- §302 - SOA'02                      HTML     45K 
13: EX-32.1     Certification -- §906 - SOA'02                      HTML     40K 
14: EX-32.2     Certification -- §906 - SOA'02                      HTML     40K 
133: R1          Cover Page                                          HTML    101K  
55: R2          Consolidated Statements of Operations               HTML    148K 
38: R3          Consolidated Statements of Comprehensive Income     HTML     73K 
                (Loss)                                                           
82: R4          Consolidated Balance Sheets                         HTML    163K 
132: R5          Consolidated Balance Sheets (Parentheticals)        HTML     59K  
54: R6          Consolidated Statements of Cash Flows               HTML    168K 
37: R7          Consolidated Statements of Shareholders' Equity     HTML    101K 
83: R8          Consolidated Statements of Shareholders' Equity     HTML     59K 
                (Parentheticals)                                                 
129: R9          Significant Accounting Policies                     HTML    452K  
135: R10         Acquisitions and Divestitures                       HTML     78K  
89: R11         Investments                                         HTML    371K 
33: R12         Fair Value                                          HTML    278K 
53: R13         Goodwill and Other Intangible Assets                HTML    139K 
134: R14         Leases                                              HTML    211K  
88: R15         Health Care Costs Payable                           HTML     99K 
32: R16         Borrowings and Credit Arrangements                  HTML    160K 
52: R17         Pension Plans and Other Postretirement Benefits     HTML    272K 
136: R18         Income Taxes                                        HTML    133K  
86: R19         Stock Incentive Plans                               HTML    146K 
31: R20         Shareholders' Equity                                HTML     62K 
80: R21         Other Comprehensive Income                          HTML    115K 
128: R22         Earnings (Loss) Per Share                           HTML     72K  
115: R23         Reinsurance                                         HTML     74K  
30: R24         Commitments and Contingencies                       HTML    109K 
79: R25         Segment Reporting                                   HTML    162K 
127: R26         Quarterly Financial Information (Unaudited)         HTML    149K  
114: R27         Significant Accounting Policies (Policies)          HTML    491K  
29: R28         Significant Accounting Policies (Tables)            HTML    295K 
81: R29         Acquisitions and Divestitures (Tables)              HTML     64K 
58: R30         Investments (Tables)                                HTML    372K 
35: R31         Fair Value (Tables)                                 HTML    264K 
84: R32         Goodwill and Other Intangibles (Tables)             HTML    127K 
130: R33         Leases (Tables)                                     HTML    144K  
59: R34         Health Care Costs Payable (Tables)                  HTML     97K 
36: R35         Borrowings and Credit Arrangements (Tables)         HTML    137K 
85: R36         Pension Plans and Other Postretirement Benefits     HTML    288K 
                (Tables)                                                         
131: R37         Income Taxes (Tables)                               HTML    131K  
57: R38         Stock Incentive Plans (Tables)                      HTML    142K 
40: R39         Shareholders' Equity (Tables)                       HTML     55K 
71: R40         Other Comprehensive Income (Tables)                 HTML    115K 
21: R41         Earnings (Loss) Per Share (Tables)                  HTML     70K 
111: R42         Reinsurance (Tables)                                HTML     73K  
122: R43         Segment Reporting (Tables)                          HTML    162K  
74: R44         Quarterly Financial Data (Tables)                   HTML    148K 
22: R45         Significant Accounting Policies - Narrative         HTML    206K 
                (Details)                                                        
112: R46         Significant Accounting Policies - Restricted Cash   HTML     52K  
                (Details)                                                        
125: R47         Significant Accounting Policies - Accounts          HTML     61K  
                Receivable (Details)                                             
70: R48         Significant Accounting Policies - Property Plant    HTML     61K 
                and Equipment (Details)                                          
24: R49         Significant Accounting Policies - Disaggregation    HTML    130K 
                of Revenue (Details)                                             
45: R50         Significant Accounting Policies - Contract          HTML     53K 
                Balances (Details)                                               
62: R51         Significant Accounting Policies - Variable          HTML     48K 
                Interest Entities (Details)                                      
146: R52         Significant Accounting Policies - Discontinued      HTML     56K  
                Operations (Details)                                             
101: R53         Significant Accounting Policies - Impact of New     HTML    105K  
                Lease Standard On Balance Sheet Line Items                       
                (Details)                                                        
42: R54         Acquisitions and Divestitures - Narrative           HTML     86K 
                (Details)                                                        
61: R55         Acquisitions and Divestitures - Assets Acquired     HTML     81K 
                and Liabilities Assumed (Details)                                
145: R56         Acquisitions and Divestitures - Pro Forma           HTML     48K  
                (Details)                                                        
98: R57         Investments - Schedule of Total Investments         HTML     54K 
                (Details)                                                        
41: R58         Investments - Narrative (Details)                   HTML     52K 
64: R59         Investments - Debt Securities (Details)             HTML     78K 
119: R60         Investments - Debt Securities by Maturity           HTML     86K  
                (Details)                                                        
108: R61         Investments - Unrealized Loss Position (Details)    HTML    117K  
28: R62         Investments - Unrealized Loss Position Maturities   HTML    102K 
                (Details)                                                        
78: R63         Investments - Mortgage Loans (Details)              HTML     45K 
116: R64         Investments - Mortgage Loans Credit Ratings         HTML     50K  
                Indicator (Details)                                              
105: R65         Investments - Schedule of Mortgage Loan Principal   HTML     52K  
                Repayments (Details)                                             
25: R66         Investments - Net Investment Income (Details)       HTML     61K 
75: R67         Investments - Realized Gains (Details)              HTML     45K 
121: R68         Fair Value - Fair Value Measurements (Details)      HTML    113K  
104: R69         Fair Value - Changes in Level 3 Financial Assets    HTML     79K  
                (Details)                                                        
90: R70         Fair Value - Gross Transfers Into (Out Of) Level 3  HTML     46K 
                (Details)                                                        
139: R71         Fair Value - Carrying Value and Fair Value          HTML     67K  
                Classified by Level (Details)                                    
65: R72         Fair Value - Separate Accounts Fair Value           HTML     72K 
                (Details)                                                        
46: R73         Fair Value - Offsetting Financial Liabilities       HTML     43K 
                (Details)                                                        
94: R74         Goodwill and Other Intangibles - Goodwill           HTML     77K 
                (Details)                                                        
142: R75         Goodwill and Other Intangibles - Narrative          HTML     74K  
                (Details)                                                        
68: R76         Goodwill and Other Intangibles - Intangible Assets  HTML     72K 
                (Details)                                                        
50: R77         Goodwill and Other Acquired Intangibles - Future    HTML     49K 
                Amortization Expense (Details)                                   
95: R78         Leases - Narrative (Details)                        HTML     65K 
137: R79         Leases - Summary of the Components of Net Lease     HTML     58K  
                Cost (Details)                                                   
91: R80         Leases - Supplemental Cash Flow Information         HTML     52K 
                (Details)                                                        
140: R81         Leases - Supplemental Balance Sheet Information     HTML     74K  
                (Details)                                                        
66: R82         Leases - Maturities of Operating and Finance Lease  HTML     99K 
                Liabilities (Details)                                            
47: R83         Leases - Rental Expense (Details)                   HTML     52K 
92: R84         Leases - Property and Equipment under Capital       HTML     50K 
                Leases (Details)                                                 
141: R85         Health Care Costs Payable - Incurred and Paid       HTML     55K  
                Health Care Claims Development (Details)                         
67: R86         Health Care Costs Payable - Narrative (Details)     HTML     42K 
48: R87         Health Care Costs Payable - Reconciliation of       HTML     54K 
                Health Care Net Incurred and Paid Claims                         
                Development to Health Care Costs Payable Liability               
                (Details)                                                        
97: R88         Health Care Costs Payable - Reconciliation of       HTML     85K 
                Health Care Costs Payable (Details)                              
138: R89         Borrowings and Credit Arrangements - Schedule of    HTML    204K  
                Debt (Details)                                                   
118: R90         Borrowings and Credit Arrangements - Debt           HTML     64K  
                Maturities (Details)                                             
107: R91         Borrowings and Credit Arrangements - Short-term     HTML    100K  
                Borrowings (Details)                                             
27: R92         Borrowings and Credit Arrangements - Long-Term      HTML    193K 
                Borrowings (Details)                                             
77: R93         Pension Plans and Other Postretirement Benefits -   HTML     73K 
                Narrative (Details)                                              
117: R94         Pension Plans and Other Postretirement Benefits -   HTML     92K  
                Benefit Obligations and Plan Assets (Details)                    
106: R95         Pension Plans and Other Postretirement Benefits -   HTML     55K  
                Net Periodic Benefit Costs (Details)                             
26: R96         Pension Plans and Other Postretirement Benefits -   HTML     47K 
                Weighted Average Assumptions Used (Details)                      
76: R97         Pension Plans and Other Postretirement Benefits -   HTML    172K 
                Fair Value of Pension Plan Assets (Details)                      
120: R98         Pension Plans and Other Postretirement Benefits -   HTML     61K  
                Changes in Level 3 Pension Plan Assets (Details)                 
103: R99         Pension Plans and Other Postretirement Benefits -   HTML     56K  
                Defined Benefit Plans Expected Benefit (Details)                 
144: R100        Income Taxes - Income Tax Provision (Details)       HTML     62K  
99: R101        Income Taxes - Narrative (Details)                  HTML     55K 
43: R102        Income Taxes - Effective Tax Rate Reconciliation    HTML     63K 
                (Details)                                                        
60: R103        Income Taxes - Deferred Tax Assets and Liabilities  HTML     85K 
                (Details)                                                        
147: R104        Income Taxes - Unrecognized Tax Benefits (Details)  HTML     53K  
100: R105        Stock Incentive Plans - Stock-Based Compensation    HTML    105K  
                Expense and ESPP (Details)                                       
44: R106        Stock Incentive Plans - Valuation and Assumptions   HTML     58K 
                (Details)                                                        
63: R107        Stock Incentive Plans - Restricted Stock Activity   HTML     63K 
                (Details)                                                        
143: R108        Stock Incentive Plans - Stock Option and SAR        HTML    121K  
                Activity (Details)                                               
102: R109        Shareholders' Equity - Repurchases (Details)        HTML     72K  
113: R110        Shareholders' Equity - Dividends (Details)          HTML     41K  
124: R111        Shareholders' Equity - Regulatory Requirements      HTML     54K  
                (Details)                                                        
73: R112        Shareholders' Equity - Noncontrolling Interests     HTML     40K 
                (Details)                                                        
23: R113        Other Comprehensive Income (Details)                HTML     86K 
110: R114        Earnings (Loss) Per Share (Details)                 HTML     91K  
123: R115        Reinsurance - Narrative (Details)                   HTML     42K  
72: R116        Reinsurance - Reinsurance Recoverables (Details)    HTML     52K 
20: R117        Reinsurance - Effects of Reinsurance (Details)      HTML     64K 
109: R118        Commitments and Contingencies (Details)             HTML     56K  
126: R119        Segment Reporting - Narrative (Details)             HTML     48K  
69: R120        Segment Reporting - Summarized Financial            HTML     91K 
                Information of Segments (Details)                                
49: R121        Segment Reporting - Reconciliation of Operating     HTML     81K 
                Earnings to Net Income (Details)                                 
93: R122        Quarterly Financial Information (Unaudited)         HTML     90K 
                (Details)                                                        
87: R9999       Uncategorized Items - a2019form10-k.htm             HTML     46K 
39: XML         IDEA XML File -- Filing Summary                      XML    263K 
51: XML         XBRL Instance -- a2019form10-k_htm                   XML   8.54M 
34: EXCEL       IDEA Workbook of Financial Reports                  XLSX    216K 
16: EX-101.CAL  XBRL Calculations -- cvs-20191231_cal                XML    558K 
17: EX-101.DEF  XBRL Definitions -- cvs-20191231_def                 XML   1.61M 
18: EX-101.LAB  XBRL Labels -- cvs-20191231_lab                      XML   3.73M 
19: EX-101.PRE  XBRL Presentations -- cvs-20191231_pre               XML   2.34M 
15: EX-101.SCH  XBRL Schema -- cvs-20191231                          XSD    342K 
96: JSON        XBRL Instance as JSON Data -- MetaLinks              770±  1.18M 
56: ZIP         XBRL Zipped Folder -- 0000064803-20-000007-xbrl      Zip    945K 


‘EX-10.27’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  
Exhibit 10.27


cvshealtha23.jpg

CVS Health Corporation
Management Incentive Plan

I.    Objectives and Summary
CVS Health Corporation’s Management Incentive Plan (the “MIP”) is designed to reward Eligible Participants of CVS Health Corporation and its subsidiaries (together, the Company) for their role in driving performance and to encourage Eligible Participants’ continued employment with the Company. Funding for the payment of incentive awards will be based on actual results measured against pre-established financial goals and/or operating goals. The amount of each incentive award paid will be based on the performance of the Company and the performance of the individual Eligible Participant.

The MIP shall be administered by the Management Planning and Development Committee (the “Committee”) of the Board of Directors (the “Board”) under the provisions herein and of the 2017 Incentive Compensation Plan or any successor plan (the “ICP”), and the Committee may delegate to officers of CVS Health the authority to perform administrative functions of the MIP as the Committee may determine and may appoint officers and others to assist it in administering the MIP.
II.    Plan Year
The MIP is a calendar year plan, which runs from January 1 to December 31 (“Plan Year”) of each year, unless otherwise approved by the Committee. All dates in this document occur during the current Plan Year unless otherwise stated.

III.    Eligibility
A. Eligibility for Participation
The Chief Executive Officer of CVS Health Corporation (“CEO”) or the CEO’s designee determines those employees who are eligible to participate in the MIP except as set forth in Section III.(B), below. In general, “Eligible Participants” are employees who are not covered by any other incentive plans and who are employed by the Company in an incentive eligible position on or before November 1 of the Plan Year.

The CEO may, for any reason and in his or her sole discretion, at any time during the Plan Year, determine an employee’s eligibility for participation in the MIP except as set forth in Section III.(B). Eligible Participants are subject to the terms and conditions relating to incentive awards set forth in the MIP.

B. Section 16 Officers
The Committee shall determine the eligibility of Section 16 Officers of CVS Health, whom will also be included in the term “Eligible Participants” unless otherwise noted. The Committee shall retain sole discretion to determine Section 16 Officer eligibility for an award, the target award, and the amount of the actual award.

C. Position Change
If a position change results in an employee becoming an Eligible Participant for part of the Plan Year and other incentives during other parts of the Plan Year, the employee may be eligible to receive an incentive award for the amount of time in each incentive eligible position, subject to the terms of each applicable incentive plan. A position change from one MIP-eligible position to another MIP-eligible position during the Plan Year also may result in a prorata award as described below under Section V.(B).





D. Demotions
If a previously Eligible Participant is demoted to a non-incentive eligible position due to his or her violation of CVS Health policy or his or her performance, or if he or she voluntarily transfers to a non-incentive eligible position during the Plan Year, and is in the non-incentive eligible position on the last day of the Plan Year, he or she will not be eligible to earn an incentive award for the Plan Year under the MIP.

E. Terminations
Unless otherwise stated in Section VII of the MIP, if an Eligible Participant’s employment terminates for any reason prior to March 1 immediately following a Plan Year, he or she will not be eligible to receive an incentive award under the MIP for the most recently completed Plan Year.

F. Rehires
Employees who are rehired as Eligible Participants on or before November 1 of the Plan Year may be eligible for an incentive award for such Plan Year.

IV.    MIP Funding
A. Consolidated Company Funding
MIP funding is based on consolidated Company performance, measured by MIP metrics as set forth in Exhibit A, for the given Plan Year. Achievement of the Company’s MIP metrics will determine the total funding (the “Total Pool”) as described below.
If any of the MIP metrics perform below threshhold, no formulaic funding will be made available for the metric of the incentive award that performed below threshold. If all MIP metrics perform below threshhold, no formulaic funding will be made available for incentive awards and there shall be no incentive awards paid under the MIP.

B. Total Pool Funding    
The Total Pool for all business units will be fully (100%) based on consolidated Company performance.
  
The CEO (or, as to Section 16 Eligible Participants, the Committee) may, for any reason and in his or her (or its) sole discretion, adjust the funding of the Total Pool based on (a) input from senior Company executives regarding their assessment of the overall performance of the Company and (b) assessment of the achievement of Plan Year performance goals.
C. Individual Performance
The Total Pool will be available for award to Eligible Participants under the MIP, taking into account the individual contribution of each Eligible Participant. The amount, if any, of the incentive award for an Eligible Participant shall be detemined in the sole discretion of the Company, which shall be final, binding and conclusive as to all parties having an interest therein. The amount, if any, of the incentive award for a Section 16 Eligible Participant shall be determined in the sole discretion of the Committee, which shall be final, binding and conclusive as to all parties having an interest therein.

V.    Earnings, Proration, and Payout
A. Timing
Incentive awards with respect to a Plan Year will be paid to Eligible Participants, as soon as administratively feasible following the date the Total Pool is determined and approved, but no later than March 15 of the calendar year immediately following the Plan Year. Incentive payments under the MIP may be subject to garnishments and other state or federal requirements.





B. Calculations
Calculations for full and partial awards for each Eligible Participant will be based on “Eligible Earnings” (defined below) for the Plan Year while in a MIP-eligible position. Eligible Earnings will be multiplied by the individual target opportunity of the Eligible Participant. If the Eligible Participant has been employed in multiple MIP-eligible positions during the Plan Year, then the individual opportunity for each position will be calculated based on the respective Eligible Earnings and individual target opportunities for each such position.

Eligible Earnings include reoccurring items such as pay earned for hours worked, paid time off (e.g. vacation, sick, holiday, funeral, jury duty, military) but will exclude one-time payments such as annual cash incentives, commissions and similar payments, and earnings associated with equity releases and stock option exercises.

For purposes of proration under the MIP and except as otherwise provided in Section VII of the MIP, calculations will be based on the number of days that the employee was an Eligible Participant in the MIP during the Plan Year.
C. Award Opportunity
Individual target award opportunities will be determined by position and may vary based on the Eligible Participant’s level in the organization.

D. Obligation to Pay Out Percentage of Total Pool
Eligible Participants, as a group, have a right to receive an amount at least equal to the Total Pool, but no individual Eligible Participant shall be entitled to receive an award or any specific amount of the Total Pool. In no event will the aggregate of the total awards paid from the MIP be less than 92.5% of the Total Pool. To discourage unmerited litigation, any party or class asserting a challenge or claim against the Company under any provision of the MIP, including this Section V, shall bear their own costs relating to such challenge or claim, and if the challenge or claim is unsuccessful, such party or class shall reimburse the Company for all reasonable costs incurred by the Company in responding to such challenge or claim.

VI.    MIP Dispute Resolution
Any questions by an Eligible Participant regarding an incentive award granted under the MIP shall first be submitted by the Eligible Participant to his or her Human Resources Business Partner (“HRBP”) within 7 days of distribution of such incentive award, and the HRBP shall submit any correction that the HRBP deems appropriate to the Compensation Department by the first business day of April immediately following the distribution date.

In the event of a dispute regarding an incentive award under the MIP after the Eligible Participant has submitted his or her question to the HRBP and received a response, as provided above, the Eligible Participant may submit an appeal for resolution of such dispute to CVS Health’s Advice and Counsel group at CVS Health, One CVS Drive, MC 1113, Woonsocket, RI 02895. Such appeal must be completed in writing within 30 days of the distribution of the incentive award. Failure to follow these procedures or submit a question or dispute in a timely manner may result in a waiver of the Eligible Participant’s right to dispute the MIP provision or amount of the incentive award.

VII. Eligible Participant Status
A. Performance
The CEO or other designated executives have full discretion in determining the amount, if any, of an incentive awarded to an Eligible Participant, and the Participant’s individual performance throughout the Plan Year will be considered by the Company in the final determination of the Eligible Participant’s incentive award.





B. Leaves of Absence
An Eligible Participant on a Company-approved leave of absence at any time during the Plan Year who remains employed in an eligible position as of the last day of the Plan Year will earn an incentive award based on Eligible Earnings (including time compensated as vacation, myTime or Paid Time Off (“PTO”)) during the Plan Year, provided he or she meets all other eligibility criteria for an incentive award.

C. Reduction in Force, Retirement and Death
1. Reduction in Force
If an Eligible Participant is separated from employment by the Company during the Plan Year due to a reduction in force, he or she may be eligible, at the Company’s discretion, to receive an incentive award based on the calculation methodology described in Section V.B above, provided the Eligible Participant meets all other eligibility criteria for an incentive award.
2. Retirement
If an Eligible Participant is at least age 55 and has a minimum of 10 years of service with CVS Health or a predecessor company/subsidiary or is at least age 60 and has a minimum of 5 years of service with CVS Health or a predecessor company/subsidiary and the Eligible Participant retires during the Plan Year, he/she may be eligible to receive an incentive award based on the calculation methodology described in Section V.B above, provided he/she meets all other eligibility criteria for an incentive award. Eligible Participants who do not meet the minimum retirement requirements under this Section VII.C.2 at the time of retirement will not be eligible for an incentive award for the Plan Year.
3. Death
In case of the death of an Eligible Participant, an incentive award may be paid to the Eligible Participant’s spouse, if living; otherwise, in equal portions to surviving children of the Eligible Participant. If there are no surviving children, the benefit shall be paid to the Eligible Participant’s estate. The incentive award will be based on the calculation methodology described in Section V.B. above.
Any incentive award payable under this section VI.C shall be paid no later than March 15 of the calendar year immediately following the Plan Year.

VIII. Miscellaneous
A. No Promise of Continued Employment
The MIP does not create an express or implied contract of employment between CVS Heath or and an Eligible Participant. Both CVS Health and the Eligible Participant retain the right to terminate the employment relationship at will, at any time and for any reason or no reason at all.
B. Rights are Non-Assignable
Neither the Eligible Participant, nor any beneficiary, nor any other person shall have any right to assign, in whole or in part, the right to receive payments under the MIP. Payments are non-assignable and non-transferable, whether voluntarily or involuntarily.

C. Compliance with Applicable Law
An Eligible Participant must comply with all applicable state and federal laws and CVS Health policies to be eligible to receive an incentive award under the MIP.

CVS Health will comply with all applicable laws concerning incentive awards; the MIP and its administration are not intended to conflict with any applicable state or federal law.
D. Change in Control




In the event of a change in control of CVS Health, as defined in the ICP, the MIP shall remain in force. Any amendments, modifications, termination or dissolution of the MIP by the acquiring entity may only occur prospectively and will not affect incentive targets or awards or eligibility in place immediately before the date of the change in control or such later date as it may be modified or dissolved by the acquiring entity.

Provisions regarding the payment of annual incentive awards that are set forth in change in control agreements with Eligible Employees shall supersede those appearing in the MIP.
E. Withholding/Taxation
All required deductions will be withheld from the incentive awards prior to distribution. This includes all applicable federal, state, or local taxes, as well as any eligible 401(k) deductions and deferred compensation contributions, in accordance with the terms of the applicable plans. Incentive awards that are deferred will be taxed in accordance with applicable federal and state tax law. Each Eligible Participant shall be solely responsible for any tax consequences of his or her award hereunder.

F. MIP Amendment/Modification/Termination
CVS Health retains the right to amend, modify, or terminate the MIP at any time on or before the last day of the Plan Year for any reason, with or without notice to Eligible Participants.

G. MIP Interpretation

CVS Health retains sole, full and final authority to prescribe rules and regulations for the administration of the Plan, construe and interpret the Plan and award agreements and correct defects, supply omissions or reconcile inconsistencies therein and to make all other decisions and determinations as it may deem necessary or advisable for the administration of the Plan.
Capitalized terms not otherwise defined herein shall have the meaning assigned to such defined term(s) in the ICP. In the event of any conflict between the ICP and the MIP, the terms of the ICP shall govern.
H. Recoupment of Incentive Awards
Each incentive award under the MIP shall be subject to the terms of the Company’s Recoupment Policy as it exists from time to time, which may require the Eligible Employee to immediately repay to the Company the value of any pre-tax economic benefit that he or she may derive from the MIP.

I. Section 409A of the Internal Revenue Code
The Company intends that the MIP not violate any applicable provision of, or result in any additional tax or penalty under, Section 409A of the Internal Revenue Code (“Code”), as amended, and the regulations and guidance thereunder (collectively, “Section 409A”), and that to the extent any provisions of the Plan do not comply with Section 409A the Company will make such changes as it deems reasonable in order to comply with Section 409A. Payments hereunder are intended to qualify as short-term deferral payments under Section 409A. In all events, the provisions of CVS Health Corporation’s Universal 409A Definition Document are hereby incorporated by reference, and notwithstanding the any other provision of the Plan or any Award to the contrary, to the extent required to avoid a violation of the applicable rules under Section 409A by reason of Section 409A(a)(2)(B)(i) of the Code (requiring certain delays for “specified employees”), payment of any amounts subject to Section 409A shall be delayed until the first business day of the seventh (7th) month following the date of termination of employment. For purposes of any provision of the Plan providing for the payment of any amounts or benefits in connection with a termination of employment, references to an Eligible Person’s “termination of employment” (and corollary terms) shall be construed to refer to the Eligible Person’s “separation from service” with the Company as determined under Section 409A.





J. Restrictive Covenant Agreement
Any award pursuant to the MIP is expressly subject to and contingent upon the requirement that the Eligible Participant shall have fully executed and delivered to the Company a restrictive covenant agreement deemed appropriate by the Company; the Company may waive such requirement in its sole discretion.  Any applicable agreement containing the restrictive covenants the Company requires in connection with this award is referred to herein as the “Restrictive Covenant Agreement.” 

If the Company requires an Eligible Participant to execute and deliver the Restrictive Covenant Agreement in connection with any MIP award, the Company shall provide such Restrictive Covenant Agreement to the Eligible Participant. The Eligible Participant must execute and deliver such agreement by the deadline set forth by the Company. The failure of an Eligible Participant to execute and return the Restrictive Covenant Agreement by the deadline set forth by the Company, if required, shall result in the immediate and irrevocable forfeiture of any MIP award.  

This Section VIII.J. of the MIP shall not constitute the Company’s exclusive remedy for Eligible Participant’s violation of the Restrictive Covenant Agreement, or failure to execute a Restrictive Covenant Agreement. The Company reserves all rights to seek all available legal or equitable remedies in the event of Eligible Participant’s violation or threatened violation of the Restrictive Covenant Agreement, including injunctive relief.





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/18/204
For Period end:12/31/1911-K,  5
 List all Filings 


12 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/07/24  CVS Health Corp.                  10-K       12/31/23  166:28M
 2/15/23  CVS Health Corp.                  424B2                  2:558K                                   Donnelley … Solutions/FA
 2/13/23  CVS Health Corp.                  424B3                  1:540K                                   Donnelley … Solutions/FA
 2/08/23  CVS Health Corp.                  10-K       12/31/22  138:26M
 2/09/22  CVS Health Corp.                  10-K       12/31/21  137:25M
 8/11/21  CVS Health Corp.                  424B2                  1:438K                                   Donnelley … Solutions/FA
 8/09/21  CVS Health Corp.                  424B3                  1:429K                                   Donnelley … Solutions/FA
 2/16/21  CVS Health Corp.                  10-K       12/31/20  137:25M
12/09/20  CVS Health Corp.                  424B2                  1:469K                                   Donnelley … Solutions/FA
12/07/20  CVS Health Corp.                  424B3                  1:424K                                   Donnelley … Solutions/FA
 8/14/20  CVS Health Corp.                  424B2                  1:473K                                   Donnelley … Solutions/FA
 8/12/20  CVS Health Corp.                  424B3                  1:459K                                   Donnelley … Solutions/FA
Top
Filing Submission 0000064803-20-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 9:42:38.1pm ET